ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+13.31%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$252M
AUM Growth
+$252M
(+8%)
Cap. Flow
+$4.74M
Cap. Flow
% of AUM
1.88%
Top 10 Holdings %
Top 10 Hldgs %
33.22%
Holding
90
New
23
Increased
14
Reduced
22
Closed
18
Top Buys
| 1 |
HubSpot
HUBS
|
$7.47M |
| 2 |
Etsy
ETSY
|
$7.44M |
| 3 |
Insulet
PODD
|
$5.9M |
| 4 |
Microsoft
MSFT
|
$5.38M |
| 5 |
XYZ
Block, Inc.
XYZ
|
$4.13M |
Top Sells
| 1 |
CTLT
CATALENT, INC.
CTLT
|
$4.77M |
| 2 |
American Airlines Group
AAL
|
$4.11M |
| 3 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$4.09M |
| 4 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$3.92M |
| 5 |
Elevance Health
ELV
|
$3.71M |
Sector Composition
| 1 | Healthcare | 38.27% |
| 2 | Technology | 28.88% |
| 3 | Communication Services | 14.71% |
| 4 | Consumer Discretionary | 7.62% |
| 5 | Materials | 4.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AdvanSix
ASIX
$576M
| $4.39M | 1.5% |
126,291
+21,291
| +20% | +$741K |
|
|
XYZ
27
Block, Inc.
XYZ
$48.5B
| $4.13M | 1.42% |
+84,000
| New | +$4.13M |
|
|
BLUE
28
DELISTED
bluebird bio
BLUE
| $4.1M | 1.4% |
24,000
-2,500
| -9% | -$427K |
|
29
Inogen
INGN
$216M
| $3.93M | 1.35% |
32,000
+11,000
| +52% | +$1.35M |
|
|
SAGE
30
DELISTED
Sage Therapeutics
SAGE
| $3.46M | 1.19% |
21,500
+15,500
| +258% | +$2.5M |
|
31
ServiceNow
NOW
$190B
| $3.31M | 1.13% |
+20,000
| New | +$3.31M |
|
32
Penumbra
PEN
$10.6B
| $3.3M | 1.13% |
+28,500
| New | +$3.3M |
|
33
Okta
OKTA
$16.4B
| $3.27M | 1.12% |
+82,000
| New | +$3.27M |
|
|
AIMT
34
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $3.12M | 1.07% |
98,000
+13,000
| +15% | +$414K |
|
35
argenx
ARGX
$43.6B
| $2.98M | 1.02% |
+37,000
| New | +$2.98M |
|
|
AZUL
36
DELISTED
Azul
AZUL
| $2.95M | 1.01% |
+85,000
| New | +$2.95M |
|
37
Esperion Therapeutics
ESPR
$448M
| $2.89M | 0.99% |
40,000
-16,000
| -29% | -$1.16M |
|
38
Q2 Holdings
QTWO
$4.92B
| $2.87M | 0.98% |
+63,000
| New | +$2.87M |
|
39
EPAM Systems
EPAM
$9.82B
| $2.86M | 0.98% |
+25,000
| New | +$2.86M |
|
|
LOXO
40
DELISTED
Loxo Oncology, Inc
LOXO
| $2.48M | 0.85% |
+21,500
| New | +$2.48M |
|
41
Vertex Pharmaceuticals
VRTX
$100B
| $2.45M | 0.84% |
15,000
+3,000
| +25% | +$489K |
|
42
DexCom
DXCM
$29.5B
| $2.37M | 0.81% |
+32,000
| New | +$2.37M |
|
43
AbbVie
ABBV
$372B
| $2.37M | 0.81% |
+25,000
| New | +$2.37M |
|
44
Nutanix
NTNX
$18B
| $2.36M | 0.81% |
+48,000
| New | +$2.36M |
|
45
JPMorgan Chase
JPM
$829B
| $2.23M | 0.76% |
20,300
+300
| +2% | +$33K |
|
|
ATVI
46
DELISTED
Activision Blizzard Inc.
ATVI
| $2.16M | 0.74% |
32,000
-42,700
| -57% | -$2.88M |
|
47
Designer Brands
DBI
$181M
| $2.16M | 0.74% |
+96,000
| New | +$2.16M |
|
48
Madrigal Pharmaceuticals
MDGL
$9.76B
| $2.1M | 0.72% |
+18,000
| New | +$2.1M |
|
49
Comerica
CMA
$9.07B
| $2.02M | 0.69% |
+21,000
| New | +$2.02M |
|
|
ZGNX
50
DELISTED
Zogenix, Inc.
ZGNX
| $2M | 0.69% |
50,000
-4,000
| -7% | -$160K |
|